Skip to content

News / Analytics / Reviews

Stock Market Analysis
Corporate News
Financial News

Earnings Summary: Abbott Laboratories tops consensus in Q2, raises FY2024 EPS outlook

Posted on July 18, 2024 by wpadmin

Posted in Corporate NewsTagged ABT

Post navigation

Previous: Nike: Oversold Value Play That Could Reward Investors In The Long Term

Next: Applied Materials: Export Controls Have Increased Competition

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Δ

Search

Recent Posts

Nvidia acquires SchedMD, which provides open-source software workload manager for HPC and AI
Texas Stock Exchange boosts capital raise to $270M as Goldman, BofA lead $20M round
Nvidia rolls out Nemotron 3 open models for building agentic AI applications
Lucid launches ‘Lucid Recharged’ program to sell certified, pre-owned EVs
Starbucks added as a new long idea at Hedgeye

Recent Comments

Tom Ford on Affirm: A Genuine Innovation In Finance
Tim Donohue on Tilray Brands Q3 Earnings: Another Disappointing Quarter
PAUL URSUL on Lucid Troubles Keep Building
Warpaint on AT&T: A Classic Value Trap
Tyrion Lannister on Microsoft: AI, A Product Development Boon

Archives

Categories

Corporate News
Financial News
Stock Market Analysis

Powered By WordPress | Newsmagify